Novo Nordisk | DETTE



Debt Changement Date
ANI Pharmaceuticals USD 622.82M 1.27M 2025-03
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.51B 106M 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.26B 828M 2024-12
Novo Nordisk 118.72B 61.75B 2025-03
Novo Nordisk DKK 56.97B 88M 2024-09
Pacira USD 583.38M 1.94M 2025-03
Perrigo USD 3.63B 9.4M 2025-03
Prestige Brands USD 1.02B 18.52M 2025-03
Sanofi 21.05B 3.14B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 6.58B 7M 2025-03



Novo Nordisk DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.